These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 21195359)

  • 21. Gender differences in cardiovascular risk factors in incident diabetes.
    Schroeder EB; Bayliss EA; Daugherty SL; Steiner JF
    Womens Health Issues; 2014; 24(1):e61-8. PubMed ID: 24439948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.
    Pérez A; Wägner AM; Carreras G; Giménez G; Sánchez-Quesada JL; Rigla M; Gómez-Gerique JA; Pou JM; de Leiva A
    Arch Intern Med; 2000 Oct; 160(18):2756-62. PubMed ID: 11025785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of a multidisciplinary intensive education program on type 2 diabetes mellitus patients' glycemic control and cardiovascular risk factors.
    Al-Arifi MN; Al-Omar HA
    Saudi Med J; 2018 Jul; 39(7):705-710. PubMed ID: 29968894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
    Simons WR; Hagan MA
    Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline and 1-year interim follow-up assessment of Japanese patients initiating insulin therapy who were enrolled in the cardiovascular risk evaluation in people with type 2 diabetes on insulin therapy study: an international, multicenter, observational study.
    Kawamori R; Node K; Hanafusa T; Atsumi Y; Naito Y; Oka Y
    Cardiovasc Diabetol; 2013 Sep; 12():131. PubMed ID: 24011395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk factors and metabolic control in type 2 diabetic subjects attending outpatient clinics in Italy: the SFIDA (survey of risk factors in Italian diabetic subjects by AMD) study.
    Comaschi M; Coscelli C; Cucinotta D; Malini P; Manzato E; Nicolucci A;
    Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):204-11. PubMed ID: 15955469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
    Vázquez LA; Rodríguez Á; Salvador J; Ascaso JF; Petto H; Reviriego J
    BMC Cardiovasc Disord; 2014 Nov; 14():153. PubMed ID: 25361574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term impact of a structured group-based inpatient-education program for intensive insulin therapy in patients with diabetes mellitus.
    Göbl CS; Dobes B; Luger A; Bischof MG; Krebs M
    Wien Klin Wochenschr; 2010 Jun; 122(11-12):341-5. PubMed ID: 20577823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlations of Serum Lipid Parameters and Atherogenic Indices With Left Ventricular Diastolic Dysfunction Among Apparently Healthy Patients With Type 2 Diabetes Mellitus: A Multicenter In-Hospital Cross-Sectional Study.
    Dienda YM; On'kin JKL; Natuhoyila AN; Lubenga Y; Swambulu TM; M'buyamba-Kabangu JR; Longo-Mbenza B; Phanzu BK
    J Diabetes Res; 2024; 2024():4078281. PubMed ID: 39035683
    [No Abstract]   [Full Text] [Related]  

  • 32. The atherogenic lipid profile is associated with type 2 diabetes and some of its treatment modalities.
    Lin M; Superko R; Williams P; Lim P; Pan J; Charles MA
    Diabetes Nutr Metab; 2003 Feb; 16(1):56-64. PubMed ID: 12848306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology.
    Franzini L; Ardigò D; Cavalot F; Miccoli R; Rivellese AA; Trovati M; Zavaroni I; Vaccaro O
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):235-41. PubMed ID: 22397873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent contribution of A1C, systolic blood pressure, and LDL cholesterol control to risk of cardiovascular disease hospitalizations in type 2 diabetes: an observational cohort study.
    Nichols GA; Joshua-Gotlib S; Parasuraman S
    J Gen Intern Med; 2013 May; 28(5):691-7. PubMed ID: 23345072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
    Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
    Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Relationship between glycemic control and visceral adiposity index among the patients with type 2 diabetes mellitus].
    Cao YY; Tang X; Sun KX; Liu ZK; Xiang X; Juan J; Song J; Duan QZ; Zhaxi DJ; Hu YN; Yang YF; Shi MY; Tian YH; Huang SP; Liu XF; Li N; Li J; Wu T; Chen DF; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):446-450. PubMed ID: 28628145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular risk factors and LDL subfraction profile in Type 2 diabetes mellitus subjects with good glycaemic control.
    Tan CE; Chew LS; Chio LF; Tai ES; Lim HS; Lim SC; Jayakumar L; Eng HK; Packard CJ
    Diabetes Res Clin Pract; 2001 Feb; 51(2):107-14. PubMed ID: 11165690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depressive symptoms, serious psychological distress, diabetes distress and cardiovascular risk factor control in patients with type 2 diabetes.
    Winchester RJ; Williams JS; Wolfman TE; Egede LE
    J Diabetes Complications; 2016 Mar; 30(2):312-7. PubMed ID: 26657725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.